AKTS:NASDAQ
Aktis Oncology Inc
US$18,52
0,00%
(0,00) 1D
US$18,52
0,00% (0,00)
bedtimeAfter hours
Closed: 2 ຕ.ລ., 16 ໂມງ 0 ນາທີ 01 ວິນາທີ GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AKTS...
Open
US$18,75
High
US$18,82
Low
US$17,93
Mkt. cap
995,39 ລ້ານ
Avg. vol.
440,07 ພັນ
Volume
337,99 ພັນ
52-wk high
US$34,19
52-wk low
US$14,72
EPS
US$-1,42
Shares outstanding
53,75 ລ້ານ
No. of employees
79
Open
US$18,75
High
US$18,82
Low
US$17,93
Mkt. cap
995,39 ລ້ານ
Avg. vol.
440,07 ພັນ
Volume
337,99 ພັນ
52-wk high
US$34,19
52-wk low
US$14,72
EPS
US$-1,42
Shares outstanding
53,75 ລ້ານ
No. of employees
79
News stories
From web sources and news partners
MarketBeat
·
2 ມື້ກ່ອນ
Aktis Oncology (NASDAQ:AKTS) Earns Outperform Rating from Wedbush
Stock Titan
·
3 ມື້ກ່ອນ
A cancer drug will be tested in lung cancer; its prostate-cancer trial is enrolling.
About Aktis Oncology Inc
CEO-
Employees79
Founded2020
Headquartersບອສຕັນ, ມາຊາຊູເຊັດ, ສະຫະລັດ
SectorBiotechnology
Websiteaktisoncology.com